FDA Adverse Event
Death
Summary report: N
BREAST IMPLANTS
MDR report key: 8753960
·
Received July 1, 2019
Report
- Report Number
- MW5087735
- Event Type
- Death
- Date Received
- July 1, 2019
- Manufacturer
- ALLERGAN INC. / MCGHAN
- Product Code
- FTR
- Report Source
- Voluntary report
- Reporter Location
- TX, US
- Reporter Occupation
- PHYSICIAN
Narratives
Description of Event or Problem · 1
THIS REPORT OF AN ALCL RELATED DEATH WAS REPORTED BY DR (B)(6) TO FDA ON 06/24/2019. PT RECEIVED IMPLANTS FOR RECONSTRUCTION. PT PRESENTED WITH A SEROMA. DATE OF PROGRESSION: (B)(6) 2007. A CAPSULECTOMY WAS PERFORMED. PT RECEIVED RADIATION THERAPY AND CHEMOTHERAPY. DATE OF DEATH IS (B)(6) 2012. CAUSE OF DEATH IS BIA-ALCL. CYTOLOGY: CD30+, CD4+, CD43+ ALK-. HISTOLOGY: MASS - INCOMPLETE RESECTION. TIME EXPOSED IS 8 YEARS. EVENT OCCURRED IN (B)(6).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 545228 | BREAST IMPLANTS | PROSTHESIS, BREAST, NON-INFLATABLE , INTERNAL, SILICONE GEL-FILLED | FTR | ALLERGAN INC. / MCGHAN | |||
| 545229 | BREAST IMPLANTS | PROSTHESIS, BREAST, NON-INFLATABLE , INTERNAL, SILICONE GEL-FILLED | FTR | ALLERGAN INC. / MCGHAN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Death |